These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 18341375)

  • 21. Old and new: evidence-based evaluation of interventions for Graves' Orbitopathy.
    Ezra DG; Rose GE
    Br J Ophthalmol; 2014 Mar; 98(3):287-8. PubMed ID: 24311524
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical assessment of patients with Graves' orbitopathy: the European Group on Graves' Orbitopathy recommendations to generalists, specialists and clinical researchers.
    ; Wiersinga WM; Perros P; Kahaly GJ; Mourits MP; Baldeschi L; Boboridis K; Boschi A; Dickinson AJ; Kendall-Taylor P; Krassas GE; Lane CM; Lazarus JH; Marcocci C; Marino M; Nardi M; Neoh C; Orgiazzi J; Pinchera A; Pitz S; Prummel MF; Sartini MS; Stahl M; von Arx G
    Eur J Endocrinol; 2006 Sep; 155(3):387-9. PubMed ID: 16914591
    [No Abstract]   [Full Text] [Related]  

  • 23. Comment on the 2021 EUGOGO Clinical Practice Guidelines for the Medical Management of Graves' Orbitopathy.
    Smith TJ
    Eur J Endocrinol; 2021 Oct; 185(6):L13-L14. PubMed ID: 34619659
    [No Abstract]   [Full Text] [Related]  

  • 24. The Amsterdam Declaration on Graves' orbitopathy.
    Perros P; Wiersinga WM
    Thyroid; 2010 Mar; 20(3):245-6. PubMed ID: 20187780
    [No Abstract]   [Full Text] [Related]  

  • 25. Pediatric thyroid-associated orbitopathy: the Children's Hospital of Philadelphia experience and literature review.
    Goldstein SM; Katowitz WR; Moshang T; Katowitz JA
    Thyroid; 2008 Sep; 18(9):997-9. PubMed ID: 18713025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Diagnosis and treatment of dysthyroid orbitopathy: a multidisciplinary disease].
    Leray B; Imbert P; Thouvenin D; Boutault F; Caron P
    J Fr Ophtalmol; 2013 Dec; 36(10):874-85. PubMed ID: 24239215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Graves' orbitopathy].
    Balázs C
    Orv Hetil; 2006 Jun; 147(22):1011-7. PubMed ID: 16913090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Combined idiopathic orbital inflammation and Graves' orbitopathy].
    Ciechanowski PP; Töteberg-Harms M; Pangalu A; Chaloupka K
    Klin Monbl Augenheilkd; 2012 Apr; 229(4):466-7. PubMed ID: 22496035
    [No Abstract]   [Full Text] [Related]  

  • 29. [What's new in endocrinology].
    Mavromati M; Leboulleux S
    Rev Med Suisse; 2022 Jan; 18(764-5):26-30. PubMed ID: 35048575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Graves' disease, consensus of the French Society of Endocrinology.
    Bartes B; Rodien P
    Ann Endocrinol (Paris); 2018 Dec; 79(6):597-598. PubMed ID: 30340757
    [No Abstract]   [Full Text] [Related]  

  • 31. Management of Graves' ophthalmopathy.
    Wiersinga WM
    Nat Clin Pract Endocrinol Metab; 2007 May; 3(5):396-404. PubMed ID: 17452966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of Graves' orbitopathy in Latin America: an international questionnaire study compared with Europe.
    Ramos HE; Diehl LA; Camacho CP; Perros P; Graf H;
    Clin Endocrinol (Oxf); 2008 Dec; 69(6):951-6. PubMed ID: 18462263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Graves'-like orbitopathy in a patient with chronic autoimmune pancreatitis.
    Fonte R; Pirali B; Caramia V; Dionisio R; Lodigiani S; Sibilla L; Rotondi M; Chiovato L
    Thyroid; 2011 Dec; 21(12):1389-92. PubMed ID: 22066480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and natural history of Graves' orbitopathy in a large series of patients with newly diagnosed graves' hyperthyroidism seen at a single center.
    Tanda ML; Piantanida E; Liparulo L; Veronesi G; Lai A; Sassi L; Pariani N; Gallo D; Azzolini C; Ferrario M; Bartalena L
    J Clin Endocrinol Metab; 2013 Apr; 98(4):1443-9. PubMed ID: 23408569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management plan and delivery of care in Graves' ophthalmopathy patients.
    Yang M; Perros P
    Best Pract Res Clin Endocrinol Metab; 2012 Jun; 26(3):303-11. PubMed ID: 22632367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum selenium status in Graves' disease with and without orbitopathy: a case-control study.
    Khong JJ; Goldstein RF; Sanders KM; Schneider H; Pope J; Burdon KP; Craig JE; Ebeling PR
    Clin Endocrinol (Oxf); 2014 Jun; 80(6):905-10. PubMed ID: 24372054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Editorial. Graves' orbitopathy.
    von Arx GF
    Orbit; 2009; 28(4):209-13. PubMed ID: 19839876
    [No Abstract]   [Full Text] [Related]  

  • 38. Editorial: Mechanisms and Novel Therapies in Graves' Orbitopathy: Current Update.
    Zhou H; Muller I; Chong KK; Ludgate M; Fang S
    Front Endocrinol (Lausanne); 2022; 13():902591. PubMed ID: 35574000
    [No Abstract]   [Full Text] [Related]  

  • 39. Management of Graves' disease: an overview and comparison of clinical practice guidelines with actual practice trends.
    Muldoon BT; Mai VQ; Burch HB
    Endocrinol Metab Clin North Am; 2014 Jun; 43(2):495-516. PubMed ID: 24891174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.
    Laurberg P; Berman DC; Andersen S; Bülow Pedersen I
    Thyroid; 2011 Sep; 21(9):951-6. PubMed ID: 21834677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.